Mycophenolate is an immunosuppressive medication that helps prevent organ rejection in transplant patients by reducing the activity of the immune system. It works by blocking an enzyme that immune cells need to multiply. The medication is being studied to understand how it interacts with the natural bacteria in the digestive system (gut microbiome) and how these bacteria might affect how the body processes the medication.

End-stage Renal Disease – A condition where kidneys permanently lose their ability to filter waste from the blood, requiring kidney transplantation or dialysis. The disease develops gradually as kidney function deteriorates over time, leading to fluid retention, electrolyte imbalances, and accumulation of waste products in the body. Patients experience various symptoms including fatigue, swelling, and changes in urination patterns.

Kidney Transplant Status – A medical condition following surgical replacement of a non-functioning kidney with a healthy donor kidney. After transplantation, the body needs to adapt to the new organ, requiring careful monitoring of organ function and immune system response. The body’s immune system naturally recognizes the new kidney as foreign tissue, which necessitates ongoing management to maintain the transplanted organ’s function.